Report cover image

In Vitro Diagnostics Business Outlook, Volume 3, Issue 5 - Point-of-Care (POC)

Publisher Kalorama Information
Published Oct 23, 2024
Length 35 Pages
SKU # KLI19272151

Description

In Vitro Diagnostics Business Outlook, Volume 3, Issue 5 - Point-of-Care (POC)


(price includes 6 issues published every two months)In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
  • A comprehensive view of the IVD market with test categories covered and company briefs
  • M&A activities, selected partnerships & collaborations, partnership deals, and more
  • Industry & region watch to help tailor strategies
  • Analysis of news and events and reporting on news not easily available

Table of Contents

35 Pages
MARKET ANALYSIS: IVD POC TESTING
OVERVIEW OF IVD POC TESTING
MARKET OUTLOOK
Table: Global POC Diagnostic Market, by Broad Segment, 2024 and 2029 ($ million) (professional testing, self-testing)
Figure: Point-of-Care Diagnostics (COVID-19 vs. non-COVID testing), 2020-2024 ($ million)
Figure: Global POC Diagnostic Market Distribution, by Segment, 2024 (%) (Cardiac Care; Coagulation; Critical Care; Drug of Abuse; Fecal Occult Blood; Glucose; Hematology; Infectious Disease Lipid [Cholesterol]; Pregnancy/Fertility; Urinalysis; Others)
Selected Product Activity
REGIONAL MARKET
Figure: POC Diagnostics Market Value, by Global Region, 2024 ($ million) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
COMPANY BRIEFS
Abbott Diagnostics
Dexcom
Roche
EXECUTIVE NEWS BRIEFING
BRIEFS
Quanterix Appoints New Member to Board of Directors
Beckman Coulter Appoints New President
MARAbio Raises $19 Million in Series A Funding
Amprion Makes Advances in Series B Financing
Sunbird Bio Closes $14 Million Financing Round
Bruker Reported 17% Growth in Second Quarter 2024 and 11% Growth for the First Six Months
Figure: Bruker Corporation Sales, by Business, H1 2023 Compared to H1 2024 (Bruker BioSpin, Bruker CALID, Bruker Nano, BEST, Eliminations)
Figure: Bruker CALID Quarterly Performance, Sales by Quarter, Q1 2022 - Q2 2024
Figure: Bruker Corporation H1 2023 and H1 2024 Regional Sales Breakdown Distribution (Asia Pacific, Japan; Europe; United States; Other)
Myriad Genetics Reports 13% Revenue Growth in First Half 2024
Table: Myriad Genetics Revenue Mix, by Product, H1 2023 vs H1 2024 ($ million) (Hereditary Cancer; Pharmacogenomics; Prenatal; Tumor Profiling)
Figure: Myriad Genetics Revenue Mix, by Business Unit, Quarterly Performance Q1 2023 through Q2 2024 ($ million) (Mental Health, Oncology, Women’s Health)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
PARTNERSHIPS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
Table: Recent Diagnostic Market Mergers, Acquisitions and Partnership Deals
INDUSTRY WATCH
INDUSTRY WATCH COVID-19/FLU UPDATE
REGION WATCH
FINLAND
Figure: Finland GDP Value and Growth, by Year, 2013-2023 ($ billion)
Figure: Finland Social Protection Expenditure by Function, 1995-2022 in 2022 Prices (€ billion)
Figure: Finland IVD Market, 2019-2024 ($ million)
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
Roche Launches TAGS Technology Test
Exact Sciences Welcomes New Cologuard Plus Test
PreAnalytiX Launches PAXgene Urine Liquid Biopsy Set
Abionic Launches Early Sepsis Test
QIAGEN Expands Liquid Biopsy Portfolio
FoundationOne Gains Liquid CDx Approval
Revvity’s Euroimmun Announces Groundbreaking Launch in the EU

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us